Stockreport

Atara Bio's tab-cell shows durable effect in mid-stage studies in EBV-associated post-transplant lymphomas; shares up 1% [Seeking Alpha]

Atara Biotherapeutics, Inc.  (ATRA) 
Last atara biotherapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.atarabio.com/investor-relations
PDF Atara Bio's tab-cell shows durable effect in mid-stage studies in EBV-associated post-transplant lymphomas; shares up 1%Long-term results from two Phase 2 clinical trial [Read more]